Stock Track | JD Health Plummets 5.31% Intraday on GLP-1 Drug Sales Regulations and Sector Weakness

Stock Track

05/18

JD Health's stock plummeted 5.31% during intraday trading on Monday, as new regulations on online sales of GLP-1 weight loss drugs and broad sector weakness pressured the online healthcare platform.

New regulations that took effect require purchasers of GLP-1 weight loss drugs to present paper prescriptions issued by physical hospitals, invalidating prescriptions from internet hospitals. This has led multiple pharmacies to delist related products from JD and other platforms, directly suppressing the company's online pharmaceutical sales business.

The Internet and Direct Marketing Retail sector faced broad selling pressure, with peers including Ali Health, PA Good Doctor, JD Group, Alibaba, and Meituan also declining, amplifying the downward move in JD Health's shares.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1147798349"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1147798349\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1147798349?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-18 10:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1147798349","market":"us","top_or_hot":-1,"title":"Stock Track | JD Health Plummets 5.31% Intraday on GLP-1 Drug Sales Regulations and Sector Weakness","media":"Stock Track","content":"<p>JD Health's stock plummeted 5.31% during intraday trading on Monday, as new regulations on online sales of GLP-1 weight loss drugs and broad sector weakness pressured the online healthcare platform.</p><p>New regulations that took effect require purchasers of GLP-1 weight loss drugs to present paper prescriptions issued by physical hospitals, invalidating prescriptions from internet hospitals. This has led multiple pharmacies to delist related products from JD and other platforms, directly suppressing the company's online pharmaceutical sales business.</p><p>The Internet and Direct Marketing Retail sector faced broad selling pressure, with peers including Ali Health, PA Good Doctor, JD Group, Alibaba, and Meituan also declining, amplifying the downward move in JD Health's shares.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | JD Health Plummets 5.31% Intraday on GLP-1 Drug Sales Regulations and Sector Weakness</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | JD Health Plummets 5.31% Intraday on GLP-1 Drug Sales Regulations and Sector Weakness\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2026-05-18 10:02</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>JD Health's stock plummeted 5.31% during intraday trading on Monday, as new regulations on online sales of GLP-1 weight loss drugs and broad sector weakness pressured the online healthcare platform.</p><p>New regulations that took effect require purchasers of GLP-1 weight loss drugs to present paper prescriptions issued by physical hospitals, invalidating prescriptions from internet hospitals. This has led multiple pharmacies to delist related products from JD and other platforms, directly suppressing the company's online pharmaceutical sales business.</p><p>The Internet and Direct Marketing Retail sector faced broad selling pressure, with peers including Ali Health, PA Good Doctor, JD Group, Alibaba, and Meituan also declining, amplifying the downward move in JD Health's shares.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06618","symbol_name":"京東健康","start_time":0,"source_url":"","article_id":"1147798349","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1147798349","pubTimestamp":1779069749,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"JD Health's stock plummeted 5.31% during intraday trading on Monday, as new regulations on online sales of GLP-1 weight loss drugs and broad sector weakness pressured the online healthcare...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06618":"京东健康"},"translate_title":"个股赛道|京东健康盘中暴跌5.31%受GLP-1药品销售监管及板块疲软影响","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06618":1},"content_text":"JD Health's stock plummeted 5.31% during intraday trading on Monday, as new regulations on online sales of GLP-1 weight loss drugs and broad sector weakness pressured the online healthcare platform.New regulations that took effect require purchasers of GLP-1 weight loss drugs to present paper prescriptions issued by physical hospitals, invalidating prescriptions from internet hospitals. This has led multiple pharmacies to delist related products from JD and other platforms, directly suppressing the company's online pharmaceutical sales business.The Internet and Direct Marketing Retail sector faced broad selling pressure, with peers including Ali Health, PA Good Doctor, JD Group, Alibaba, and Meituan also declining, amplifying the downward move in JD Health's shares.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}